CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 141 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $373,893 | +61.1% | 31,984 | +85.2% | 0.01% | +55.6% |
| Q2 2023 | $232,096 | -91.1% | 17,269 | -89.0% | 0.01% | -91.7% |
| Q1 2023 | $2,598,451 | +76.1% | 156,722 | +97.6% | 0.11% | +38.5% |
| Q4 2022 | $1,475,519 | +142.3% | 79,329 | +67.0% | 0.08% | +225.0% |
| Q3 2022 | $609,000 | +6.1% | 47,500 | -42.0% | 0.02% | -4.0% |
| Q2 2022 | $574,000 | -33.1% | 81,901 | -20.9% | 0.02% | -32.4% |
| Q1 2022 | $858,000 | +3.5% | 103,494 | -15.4% | 0.04% | -28.8% |
| Q4 2021 | $829,000 | +278.5% | 122,400 | +222.2% | 0.05% | +147.6% |
| Q2 2021 | $219,000 | -13.8% | 37,983 | -31.1% | 0.02% | -12.5% |
| Q1 2021 | $254,000 | +62.8% | 55,100 | +5.0% | 0.02% | -22.6% |
| Q3 2020 | $156,000 | – | 52,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |